Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To document the clinical condition of patients who were included in the REGULATE trial and exposed to the investigational drugs (benfluorex or pioglitazone).
Critère d'inclusion
- Type II Diabetes,The medical condition investigated in the REGULATE trial (CL3-00780-148) was type II diabetes. The applied CL3-00780-150 trial, REGULATE follow-up study, is thus performed in diabetic patients